Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

Nanjing Legend Raises $150 Million for Cell Therapies in an A Round/Pre-IPO Financing

Boston's Rgenta Raises $20 Million for RNA Therapies from China-Heavy Syndicate

Ping An Invests $311 Million in Japan's Shionogi for New Drug Development

Ocumension Enters $77 Million Deal for Stem Cell Therapies from Japan's SanBio

ZhenGe Biotech Completes $51 Million A Round for CDMO Operations

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China